- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05487872
Mindfulness and Psychological Inflexibility
August 2, 2022 updated by: Buse Keskindag, Bahcesehir Cyprus University
Mindfulness Skills Training and Psychological Inflexibility: a Randomized Trial
This study aimed to examine whether mindfulness skills training can help to reduce experiential avoidance and anxiety level.
This study investigated whether the training delivery methods (audio-guided mindfulness exercise or virtual reality-based mindfulness exercise) differ in terms of changing general experiential avoidance and anxiety symptoms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The experimental design (randomized trial) was used in this study.
Data were collected through convenience sampling.
After obtaining ethical approval fromEthics Committee of the Bahçeşehir Cyprus University, participants were invited to participate in the study via advertisements posted in the university building.
Recruited participants were randomly assigned to the experimental group or control group.
All participants will be provided with an informed consent form which provided information about participant's right and data management.
Participants in the experimental group completed mindfulness exercise on Virtual Reality (VR) system where they listened to an audio track (guide for the exercise) and saw calming nature scenes (e.g., views on the beach) whereas those in the control group completed mindfulness exercise by listening to the (same) audio track only.
Each mindfulness session took approximately 15 mins.
In total, four sessions were completed in two weeks (2 sessions per week).
After obtaining informed consent, the participants completed a survey pack that included valid and reliable measurement scales (mindfulness skills [The Cognitive and Affective Mindfulness Scale - Revised], experiential avoidance [Acceptance and Action Questionnaire-II], and anxiety symptoms [Generalized Anxiety Disorder Scale]) at two-time points (i.e., pre-test [before intervention], and post-test [after 4 sessions/when sessions were completed], At the end of the study, the participants were provided with a debrief form.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nicosia, Cyprus
- Bahcesehir Cyprus University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age of 18 and above,
- ability to read, and/or understand English
Exclusion Criteria:
- Participants who regularly practice mindfulness exercise were excluded form the analyses
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Audio-guided mindfulness skills training
Participants in this group listened to a 15 mins audio track to practice mindfulness exercises
|
The intervention aimed to increase participants' mindfulness skills which may be critical in decreasing general experiential avoidance and anxiety symptoms
|
Experimental: Virtual reality (VR) -based mindfulness skills training
Participants in this group completed mindfulness exercises on the VR system.
The system included the same 15 mins audio track and additionally a video that displayed a 360° spherical landscape view of the sea in the afternoon
|
The intervention aimed to increase participants' mindfulness skills which may be critical in decreasing general experiential avoidance and anxiety symptoms
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in experiential avoidance
Time Frame: at two time points (pre-intervention and immediately after the intervention)
|
Experiential avoidance is an example of psychological inflexibility.
Experiential avoidance was measured via Acceptance and Action Questionnaire-II.
The scale includes 7 items that are rated on a seven-point scale (1 = never true - 7 = always true).
The minimum and maximum scores on the scale range between 7 and 49 points.
Higher scores on the scale indicate greater experiential avoidance (psychological inflexibility)
|
at two time points (pre-intervention and immediately after the intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in anxiety
Time Frame: at two time points (pre-intervention and immediately after the intervention)
|
Anxiety symptoms were measured via Generalized Anxiety Disorder Scale.
The scale includes 7 items rated on 4 point scale (0 = Not at all, 1 = Several days, 2 = More than half of the days - 3 = Nearly every day).
Scores 5, 10, 15 obtained from the test indicate mild, moderate, and severe anxiety, respectively.
|
at two time points (pre-intervention and immediately after the intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Buse Keskindag, Bahcesehir Cyprus University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 2, 2022
Primary Completion (Actual)
June 24, 2022
Study Completion (Actual)
June 24, 2022
Study Registration Dates
First Submitted
July 30, 2022
First Submitted That Met QC Criteria
August 2, 2022
First Posted (Actual)
August 4, 2022
Study Record Updates
Last Update Posted (Actual)
August 4, 2022
Last Update Submitted That Met QC Criteria
August 2, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- BAU/EK-2022/02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mindfulness
-
Chinese University of Hong KongCompleted
-
Vanderbilt UniversityUniversity of California, Los Angeles; Northwestern UniversityCompletedMindfulnessUnited States
-
Medical Research Council Cognition and Brain Sciences...University of CambridgeActive, not recruiting
-
Mersin Training and Research HospitalCompletedMental Health | MindfulnessTurkey
-
University of LuxembourgLuxembourg National Research Fund (FNR)CompletedHealthy Aging | MindfulnessLuxembourg
-
Massachusetts General HospitalCompletedMindfulness | Orthopaedic InjuryUnited States
-
Northwestern UniversityUniversity of Pittsburgh; National Institutes of Health (NIH); National Center...CompletedCreating and Optimizing Mindfulness Measures to Enhance and Normalize Clinical Evaluation (COMMENCE)MindfulnessUnited States